NCT01630369 Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01625494 Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy Status COMPLETED Phase PHASE3
NCT01623115 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy Status COMPLETED Phase PHASE3
NCT01621776 Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia Status COMPLETED Phase NA
NCT01617655 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) Status COMPLETED Phase PHASE3
NCT01606384 Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01604824 A Study of Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of-Function Mutations (GOFm) of the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene or Loss-of-Function Mutations (LOFm) of the Apolipoprotein (Apo) B Gene Status COMPLETED Phase PHASE2
NCT01598415 Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II Status COMPLETED Phase PHASE2
NCT01596504 Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin Status COMPLETED Phase PHASE2
NCT01596270 A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT01594918 Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT01593228 Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial Status COMPLETED Phase PHASE3
NCT01587040 Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen Status COMPLETED Phase PHASE1/PHASE2
NCT01586338 A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s) Status COMPLETED Phase PHASE4
NCT01576484 Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) Status COMPLETED Phase PHASE2
NCT01576029 Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT01572649 Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01571284 Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen Status COMPLETED Phase PHASE3
NCT01567904 Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line Status TERMINATED Phase PHASE2